-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Oncotelic Therapeutics, Inc. quarterly/annual Return On Equity history and change rate from Q3 2019 to Q3 2025.
- Oncotelic Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -22.2 %, a 49.5% increase year-over-year.
- Oncotelic Therapeutics, Inc. annual Return On Equity for 2024 was -47.2 %, a 19.3% increase from 2023.
- Oncotelic Therapeutics, Inc. annual Return On Equity for 2023 was -58.5 %, a 312% decline from 2022.
- Oncotelic Therapeutics, Inc. annual Return On Equity for 2022 was 27.6 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)